trending Market Intelligence /marketintelligence/en/news-insights/trending/lg2mpn_sfd9ytzw9nnfmgw2 content esgSubNav
In This List

Beleave appoints 2 directors

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Beleave appoints 2 directors

Canada-based Beleave Inc. appointed Mark Heselton and Mark Miles to the board.

Heselton is currently senior vice president for global partner business at iron replacement therapy company Vifor Pharmaceuticals.

Miles is the president of M2PM Ltd. and has more than 35 years of experience in the construction and development industries.